ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02733042
Brief Title: A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia (FUSION NHL 001)

First Submitted : April 5, 2016
First Submitted that Met QC Criteria : April 5, 2016
First Posted : April 11, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 16, 2018
Last Update Posted : October 17, 2018